| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CUDC-101 | GDSC1000 | pan-cancer | AAC | -0.063 | 0.06 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | -0.088 | 0.06 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | 0.11 | 0.06 |
| mRNA | A-770041 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.06 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | 0.11 | 0.06 |
| mRNA | Tamoxifen | CTRPv2 | pan-cancer | AAC | -0.07 | 0.06 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | -0.093 | 0.07 |
| mRNA | MI-2 | CTRPv2 | pan-cancer | AAC | -0.099 | 0.07 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | -0.088 | 0.07 |
| mRNA | Topotecan | FIMM | pan-cancer | AAC | 0.2 | 0.07 |